Search

Search Results
Results 8261 - 8270 of 9102 for Abnormalities
  • Codral Original Cold & Flu Tablets
    Drug - 7 Jan 2026
    Consumer Medicine Information (CMI) about Codral Original Cold & Flu Tablets intended for persons living in Australia.
  • Metomax
    Drug - 21 Nov 2025
    Consumer Medicine Information (CMI) about Metomax intended for persons living in Australia.
  • DBL Diazoxide
    Drug - 9 Nov 2025
    Consumer Medicine Information (CMI) about DBL Diazoxide intended for persons living in Australia.
  • Panadol Sinus Relief Original Formula
    Drug - 4 Nov 2025
    Consumer Medicine Information (CMI) about Panadol Sinus Relief Original Formula intended for persons living in Australia.
  • Panadol Allergy Sinus
    Drug - 4 Nov 2025
    Consumer Medicine Information (CMI) about Panadol Allergy Sinus intended for persons living in Australia.
  • Rixadone
    Drug - 11 Aug 2025
    Consumer Medicine Information (CMI) about Rixadone intended for persons living in Australia.
  • Augtyro
    Drug - 30 Jul 2025
    Consumer Medicine Information (CMI) about Augtyro intended for persons living in Australia.
  • Good practices for NGS panel customization
    White Paper - 17 Jan 2025
    In this article, Cerba discussed good practices and gives advice on NGS panel customization.
  • Dantrium Capsules
    Drug - 11 Nov 2024
    Consumer Medicine Information (CMI) about Dantrium Capsules intended for persons living in Australia.
  • Neurological diseases: Advancements in live-cell analysis
    White Paper - 3 Jun 2024
    This article talks about the complexities of neurological diseases and injuries and how real-time, live-cell analysis can be used to unravel their complexities.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback